Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02919436 · ClinicalTrials.gov registry record · Phase 4
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
A Phase 4 study of Post-Operative Urinary Retention, sponsored by Anand Rughani, MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 610
- Enrollment target
- 1
- Study location
NCT02919436 is a Phase 4 study of Post-Operative Urinary Retention that has completed, run by Anand Rughani, MD. The registered enrollment target is 610 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02919436, a Phase 4 study of Post-Operative Urinary Retention, has completed, sponsored by Anand Rughani, MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 610 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Study Locations (1)
Maine
- Maine Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02919436
The ClinicalTrials.gov registry entry for NCT02919436 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anand Rughani, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Operative Urinary Retention appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02919436 reports 1 study location spanning 1 distinct geographic area - top geographies include Maine.
Frequently Asked Questions
What is clinical trial NCT02919436 about?
NCT02919436 is a clinical study titled "Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery". Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
What is the current status of trial NCT02919436?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 610 participants. The study started on 2016-03. Estimated completion is 2020-11.
What conditions does trial NCT02919436 study?
This clinical trial studies the following conditions: Post-Operative Urinary Retention.
What interventions are being tested in trial NCT02919436?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT02919436?
This trial is sponsored by Anand Rughani, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02919436 being conducted?
This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Operative Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.